Penumbra Inc
PEN- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001321732
No open-market purchases or sales by Penumbra Inc insiders were filed in the last 90 days; 451 institutions reported holding it in 13F filings for Q2 2026, worth $10.8B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Penumbra Inc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 287
- +16 vs. Q1 2021
- Shares held
- 29.8M
- −955.0K (−3.1%) vs. Q1 2021
- Total value
- $8.17B
- −$155.6M (−1.9%) vs. Q1 2021
- New holders
- 47
- 96 more added
- Sold out
- 31
- 97 more reduced
2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 451 | $10.8B |
| Q1 2026 | 485 | $11.1B |
| Q4 2025 | 440 | $11.4B |
| Q3 2025 | 421 | $9.19B |
| Q2 2025 | 451 | $9.18B |
| Q1 2025 | 421 | $9.39B |
| Q4 2024 | 372 | $8.30B |
| Q3 2024 | 334 | $6.85B |
| Q2 2024 | 342 | $6.40B |
| Q1 2024 | 342 | $7.52B |
| Q4 2023 | 339 | $8.66B |
| Q3 2023 | 317 | $8.01B |
| Q2 2023 | 364 | $11.8B |
| Q1 2023 | 312 | $9.74B |
| Q4 2022 | 290 | $7.67B |
| Q3 2022 | 261 | $6.06B |
| Q2 2022 | 255 | $3.91B |
| Q1 2022 | 280 | $6.71B |
| Q4 2021 | 279 | $8.72B |
| Q3 2021 | 280 | $7.94B |
| Q2 2021 | 287 | $8.17B |
| Q1 2021 | 273 | $8.40B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Penumbra Inc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LS Investment Advisors, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Capital Bank & Trust Co | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Marcum Wealth, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −1,971−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −1,933−100.0% | Sold out |
| Range Financial Group LLC | 0 | $0 | 0.00% | −1,360−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −1,254−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −896−100.0% | Sold out |
| QS Investors, LLC | 0 | $0 | 0.00% | −745−100.0% | Sold out |
| NN Investment Partners Holdings N.V. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Botty Investors LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −240−100.0% | Sold out |
| Kistler-Tiffany Companies, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Charter Oak Capital Management, LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Waddell & Reed Financial Inc | – | – | – | – | Not filed |
| Amundi Asset Management US, Inc. | – | – | – | – | Not filed |